Synovial Sarcoma Foundation Welcomes Julie Kramer as Community Engagement & Partnerships Manager

Synovial Sarcoma Foundation Welcomes Julie Kramer as Community Engagement & Partnerships Manager

Current Patient to Drive Relationships and Support for the Synovial Sarcoma Community [Philadelphia, PA] – 12/12/25 – The Synovial Sarcoma…

Arizona Pioneers New Immune Therapy for Synovial Sarcoma Treatment

Arizona Pioneers New Immune Therapy for Synovial Sarcoma Treatment

In a groundbreaking advancement in cancer treatment, a patient with synovial sarcoma in Arizona has become the first in the…

Revolutionary Insights Unveiled in Latest Synovial Sarcoma Research

Revolutionary Insights Unveiled in Latest Synovial Sarcoma Research

A landmark study just published in Nature Communications finally pinpointed the exact “cell of origin” for synovial sarcoma — a rare, primitive…

2025 Connective Tissue Oncology Society

2025 Connective Tissue Oncology Society

The Synovial Sarcoma Foundation is excited to share that we are on site this week at the 2025 Connective Tissue Oncology Society…

Rise in Early-Onset Cancers: More Diagnoses, Not Always More Disease

Rise in Early-Onset Cancers: More Diagnoses, Not Always More Disease

Not every detected cancer is clinically meaningful. For younger patients, especially, this can mean confronting a diagnosis that may never…

Dr. Theodore W. Laetsch, Synovial Sarcoma Foundation Board Member, Receives $1 Million Grant to Advance Rare Tumor Studies

Dr. Theodore W. Laetsch, Synovial Sarcoma Foundation Board Member, Receives $1 Million Grant to Advance Rare Tumor Studies

The Synovial Sarcoma Foundation is pleased to highlight a significant milestone at the Children’s Hospital of Philadelphia (CHOP), where pediatric…

Innovative Approach Shows Promise Against Synovial Sarcoma Using Protein-Blocking Drugs

Innovative Approach Shows Promise Against Synovial Sarcoma Using Protein-Blocking Drugs

The Synovial Sarcoma Foundation is dedicated to supporting cutting-edge research that advances treatment options for this rare and aggressive cancer.…

New Market Insights Highlight Growth in Synovial Sarcoma Treatments

New Market Insights Highlight Growth in Synovial Sarcoma Treatments

The Synovial Sarcoma Foundation is committed to staying informed on the latest research and developments in this rare and aggressive…

The Latest Synovial Sarcoma Data

A Global Survey for

Doctors Researchers Patients Advocates

Understanding the experiences of Synovial Sarcoma patients is essential to identifying challenges, improving treatment, and advancing research. Access comprehensive survey results by joining our Facebook Group, where you can connect with others in the community.

A data table displaying survey results for synovial sarcoma, including patient gender, age, location, primary tumor site, year diagnosed, tumor size, metastasis status, chemotherapy, radiation, surgery, NED duration, and recurrence location.